Central nervous system tuberculosis

African Health Sciences

Volumn 11, Issue 1, 2011, Pages 116-127

  Cherian, Ajith ^a   Thomas, S V ^b  

^a GOVERNMENT MEDICAL COLLEGE   (India)

^b SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

Author keywords

Drug resistant; Human immunodeficiency virus; Meningitis; Mycobacterium; Steroids

Indexed keywords

ADENOSINE DEAMINASE; AMINOSALICYLIC ACID; ANTIRETROVIRUS AGENT; BCG VACCINE; CORTICOSTEROID; DELAVIRDINE; DEXAMETHASONE; EFAVIRENZ; ETHAMBUTOL; GAMMA INTERFERON; ISONIAZID; LEVOFLOXACIN; MOXIFLOXACIN; NEVIRAPINE; PREDNISOLONE; PROTEINASE INHIBITOR; PYRAZINAMIDE; PYRIDOXINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFABUTIN; RIFAMPICIN; STREPTOMYCIN; THALIDOMIDE; TUBERCULOSTATIC AGENT; TUBERCULOSTEARIC ACID;

ABDUCENS NERVE PARALYSIS; ALBUMIN BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; BIOPSY TECHNIQUE; BRAIN VENTRICLE PERITONEUM SHUNT; CENTRAL NERVOUS SYSTEM INFECTION; CENTRAL NERVOUS SYSTEM TUBERCULOSIS; CEREBROSPINAL FLUID EXAMINATION; CLINICAL FEATURE; COMA; COMPUTER ASSISTED TOMOGRAPHY; DOPPLER ECHOGRAPHY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG METABOLISM; DRUG OVERDOSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; GLASGOW COMA SCALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROCEPHALUS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INFECTION RISK; INTRACRANIAL TUBERCULOMA; LUNG TUBERCULOSIS; METABOLIC ACIDOSIS; NEUROLOGICAL COMPLICATION; NEUROSURGERY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; OPTIC NEURITIS; PATIENT COMPLIANCE; POLYMERASE CHAIN REACTION; PREVALENCE; PROGNOSIS; PROTHROMBIN TIME; RECOMMENDED DRUG DOSE; SEIZURE; SIDE EFFECT; SPINAL CORD COMPRESSION; SPUTUM SMEAR; TOXIC HEPATITIS; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOUS ENCEPHALOPATHY; TUBERCULOUS MENINGITIS; TUBERCULOUS SPONDYLITIS;

ANTITUBERCULAR AGENTS; HUMANS; MYCOBACTERIUM TUBERCULOSIS; RISK FACTORS; TUBERCULIN TEST; TUBERCULOSIS, CENTRAL NERVOUS SYSTEM; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 79953757886     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. WHO, editor. Global tuberculosis control 2009: surveillance, planning, financing. Geneva: World Health Organization; 2009. p. 1-303.
2. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Dye C. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med. 2003; 163:1009-21.
3. UNAIDS. HIV epidemiology. Available at: http:// www.unaids.org/en/KnowledgeCentre/HIVData/ Epidemiology/latestEpiData.asp. 20
4. Harries AD, Zachariah R, Lawn SD. Providing HIV care for co-infected tuberculosis patients:a perspective from sub-Saharan Africa. Int J Tuberc Lung Dis 2009;13:6-16.
5. Corbett EL, Charalambous S, Moloi VM, Fielding K, Grant AD, Dye C, et al Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold miners. Am J Respir Crit Care Med 2004;170:673-9.
6. Rieder, H. L., D. E. Snider, Jr., G. M. Cauthen. Extrapulmonary tuberculosis in the United States. Am Rev Respir Dis 1990; 141:347-351.
7. CDC. 2005. Extrapulmonary tuberculosis cases and percentages by site of disease: reporting areas, 2005. Centers for Disease Control and Prevention, Atlanta, GA. www. cdc.gov/tb/surv/surv2005/PDF/ table27.pdf.
8. Lu, T. H., R. M. Huang, T. D. Chang, S. M. Tsao, T. C. Wu. Tuberculosis mortality trends in Taiwan: a resurgence of non-respiratory tuberculosis. Int. J. Tuberc. Lung Dis 2005; 9:105-110.
9. Rana, F. S., M. P. Hawken, C. Mwachari, S. M. Bhatt, F. Abdullah, L. W. Ng'_ang'a, C. Power, W. A. Githui, J. D. Porter, S. B. Lucas. Autopsy study of HIV-1-positive and HIV-1-negative adult medical patients in Nairobi, Kenya. J Acquir Immune Defic Syndr 2000;24:23-29
10. Yaramis, A., F. Gurkan, M. Elevli, M. Soker, K. Haspolat, G. Kirbas, and M. A. Tas. Central nervous system tuberculosis in children: a review of 214 cases. Pediatrics 1998; 102:E49.
11. Phypers, M., T. Harris, C. Power. CNS tuberculosis: a longitudinal analysis of epidemiological and clinical features. Int J Tuberc Lung Dis 2006; 10:99-103.
12. Bidstrup C, Andersen PH, Skinhoj P, Andersen AB. Tuberculous meningitis in a country with a low incidence of tuberculosis: still a serious disease and a diagnostic challenge. Scand J Infect Dis. 2002;34:811-4.
13. Ravindra Kumar Garg. Tuberculosis of the central nervous system Postgrad Med J 1999 75: 133-140.
14. Sutlas PN, Unal A, Forta H., Senol S., Kirbas D. Tuberculous meningitis in adults: review of 61 cases. Infection 2003;31:387-91.
15. Thwaites, GE., N. D. Bang, N. H. Dung, HT Quy, DTT Oanh, NTC. Thoa, NQHien, N. T. Thuc, NN Hai, NTN Lan, NNLan, NHDuc, VN Tuan, CH Hiep, T T H Chau, P P Mai, NT Dung, K. Stepniewska, CP Simmons, NJ White, TT Hien, JJ Farrar. The influence of HIV infection on clinical presentation, response to treatment, and outcome in adults with tuberculous meningitis. J. Infect. Dis. 2005; 192:2134-41.
16. Lammie GA, Hewlett RH, Schoeman JF, Donald PR. Tuberculous cerebrovascular disease: a review. J Infect. 2009;59:156-66.
17. Donald, P. R., H. S. Schaaf, J. F. Schoeman. Tuberculous meningitis and miliary tuberculosis: the Rich focus revisited. J. Infect. 2005; 50:193-5.
18. Thwaites, G. E., T. H. Tran. Tuberculous meningitis: many questions, too few answers. Lancet Neurol. 2005;4:160-70.
19. Berger JR. Tuberculous meningitis. Curr Opin Neurol 1994;7:191-200.
20. Leonard JM, Des Prez RM. Tuberculous meningitis. Infect Dis Clin North Am 1990;4: 769-87.
21. Kumar R., C. K. Pandey, N. Bose, S. Sahay. Tuberculous brain abscess: clinical presentation, pathophysiology and treatment (in children). Childs Nerv. Syst. 2002;18:118-23.
22. Ahuja GK, Mohan KK, Prasad K, Behari M. Diagnostic criteria for tuberculous meningitis and their validation. Tubercle Lung Dis 1994;75:149-52.
23. Kumar R, Singh SN, Kohli N. A diagnostic rule for tuberculous meningitis. Arch Dis Child 1999;81(3):221-4.
24. Youssef FG, Afifi SA, Azab AM, Wasfy MM, Abdel-Aziz KM, Parker TM, et al. Differentiation of tuberculous meningitis from acute bacterial meningitis using simple clinical and laboratory parameters. Diagn Microbiol Infect Dis. 2006; 55:275-8.
25. Thwaites GE, Chau TT, Stepniewska K, Phu NH, Chuong LV, Sinh DX, White NJ, Parry CM, Farrar JJ. Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. Lancet. 2002; 360:1287-92.
26. Moghtaderi A, Alavi-Naini R, Izadi S, Cuevas LE. Diagnostic risk factors to differentiate tuberculous and acute bacterial meningitis. Scand J Infect Dis. 2009;41:188-94
27. Dastur DK. The pathology and pathogenesis of tuberculous encephalopathy and radiculomyelopathy:a comparison with allergic encephalomyelitis. Childs Nerv Syst. 1986; 2:139.
28. Vidyasagar C, Murthy HKRS. Management of tuberculosis of the spine with neurological complications. Ann J Coll Surg Engl 1994;76:80-4.
29. Dastur HM. Diagnosis and neurosurgical treatment of tuberculous diseases of the CNS Neurosurg Rev 1983;6:111-9.
30. Meintjes G, Lawn SD, Scano F, Maartens G, French MA, Worodria W, Elliott JH, et al. Tuberculosisassociated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis. 2008;8:516-23.
31. Narita M, Ashkin D, Hollender ES, Pitchenik AE. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med. 1998;158:157-61
32. Venkataswamy MM, Rafi W, Nagarathna S, Ravi V, Chandramuki A. Comparative evaluation of BACTEC 460TB system and Lowenstein-Jensen medium for the isolation of M. tuberculosis from cerebrospinal fluid samples of tuberculous meningitis patients. Indian journal of medical microbiology. 2007;25:236-40.
33. Pai M, Flores LL, Pai N, Hubbard A, Riley LW, Colford JM. Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: a systematic review and meta-analysis. The Lancet infectious diseases. 2003;3:633-43.
34. Thwaites GE, Caws M, Chau TT, Dung NT, Campbell JI, Phu NH, et al. Comparison of conventional bacteriology with nucleic acid amplification (amplified mycobacterium direct test) for diagnosis of tuberculous meningitis before and after inception of antituberculosis chemotherapy. Journal of clinical microbiology. 2004;42:996-1002.
35. Thwaites G, Fisher M, Hemingway C, Scott G, Solomon T, Innes J; British Infection Society. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect. 2009;59:167-87.
36. Takahashi T, Tamura M, Asami Y, Kitamura E, Saito K, Suzuki T, et al. Novel "wide range" quantitative nested real-time PCR assay for Mycobacterium tuberculosis DNA-Development and Methodology. Journal of clinical microbiology. 2008 Mar 12.
37. Kilpatrick ME, Girgis NI, Tribble D, Farid Z. The value of the tuberculin skin test in patients with tuberculous meningitis. The Journal of the Egyptian Public Health Association. 1996;71:1-8.
38. Mahadevan B, Mahadevan S, Serane VT, Narasimhan R. Tuberculin reactivity in tuberculous meningitis. Indian journal of pediatrics. 2005;72:213-5.
39. Joos TJ, Miller WC, Murdoch DM. Tuberculin reactivity in bacille Calmette-Guerin vaccinated populations: a compilation of international data. Int J Tuberc Lung Dis. 2006;10:883-91.
40. Simmons CP, Thwaites GE, Quyen NT, Torok E, Hoang DM, Chau TT, et al. Pretreatment intracerebral and peripheral blood immune responses in Vietnamese adults with tuberculous meningitis: diagnostic value and relationship to disease severity and outcome. J Immunol. 2006;176:2007-14.
41. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007;146:340-54.
42. Pai M, Zwerling A, Menzies D. T-cell based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008;149:177-84.
43. Farhat M, Greenaway C, Pai M, Menzies D. Falsepositive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis. 2006;10:1192-204.
44. Pai M, Dheda K, Cunningham J, Scano F, O'Brien R. T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward. Lancet Infect Dis. 2007;7:428-38.
45. Dheda K, van Zyl Smit R, Badri M, Pai M. T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings. Curr Opin PulmMed 2009;15:188-200.
46. Kashyap, R. S., R. P. Kainthla, A. V. Mudaliar, H. J. Purohit, G. M. Taori, H. F. Daginawala. Cerebrospinal fluid adenosine deaminase activity: a complementary tool in the early diagnosis of tuberculous meningitis. Cerebrospinal Fluid Res 2006; 3:5.
47. Rock RB, Olin M, Baker CA, Molitor TW, Peterson PK. Central nervous system tuberculosis: pathogenesis and clinical aspects. Clin Microbiol Rev. 2008;21:243-61
48. Corral, C. Quereda E. Navas, P. Martin-Davila, M J. Perez-Elias JL. Casado, V. Pintado J. Cobo, E. Pallares, J. Rubi, S. Moreno. Adenosine deaminase activity in cerebrospinal fluid of HIV-infected patients:limited value for diagnosis of tuberculous meningitis. Eur. J. Clin. Microbiol. Infect. Dis. 2004. 23:471-76.
49. Jakka SS, Veena AR, Rao M. Eisenhut. Cerebrospinal fluid adenosine deaminase levels and adverse neurological outcome in pediatric tuberculous meningitis. Infection. 2005;33:264-66.
50. Schutte CM, JP. Ungerer H. du Plessis, CH. van der Meyden. Significance of cerebrospinal fluid adenosine deaminase isoenzymesm in tuberculous (TB) meningitis. J. Clin. Lab. Anal. 2001;15:236-38.
51. Corral I, Quereda C, Navas E, Martin-Davila P, Perez-Elias MJ, Casado JL, et al. Adenosine deaminase activity in cerebrospinal fluid of HIV-infected patients: limited value for diagnosis of tuberculous meningitis. Eur J Clin Microbiol Infect Dis. 2004;23:471-6.
52. Brooks JB., Daneshvar MI, RL. Haberberger Mikhal A. Rapid diagnosis of tuberculous meningitis by frequency-pulsed electroncapture gas-liquid chromatography detection of carboxylic acids in cerebrospinal fluid. J. Clin. Microbiol. 1990;28:989-97.
53. Roos KL. Pearls and pitfalls in the diagnosis and management of central nervous system infectious diseases. Semin Neurol 1998;18:185-96.
54. Andronikou S, Smith B, Hatherhill M, Douis H, Wilmshurst J. Definitive neuroradiological diagnostic features of tuberculous meningitis in children. Pediatric radiology. 2004;34:876-85.
55. Wasay M, Kheleani BA, Moolani MK, Zaheer J, Pui M, Hasan S, et al. Brain CT and MRI findings in 100 consecutive patients with intracranial tuberculoma. J Neuroimaging. 2003;13:240-7.
56. Kingsley PB, Shah TC, Woldenberg R. Identification of diffuse and focal brain lesions by clinical magnetic resonance spectroscopy. NMR Biomed. 2006;19:435-62.
57. Kiliç T, Elmaci I, Ozek MM, Pamir MN. Utility of transcranial Doppler ultrasonography in the diagnosis and follow-up of tuberculous meningitis-related vasculopathy. Childs Nerv Syst. 2002;18:142-6.
58. Fox W, Ellard GA, Mitchison DA. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council Tuberculosis Units,1946-1986. Int J Tuberc Lung Dis 1999;3: S231-79
59. World Health Organization. Treatment of tuberculosis: guidelines for national programmes. Geneva:World Health Organization; 2003. WHO/ CDS/TB/2003.313.
60. Jindani A, Nunn AJ, Enarson DA. Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial. Lancet 2004;364:1244-51.
61. Ellard GA, Humphries MJ, Allen BW. Cerebrospinal fluid drug concentrations and the treatment of tuberculous meningitis. Am Rev Respir Dis. 1993;148:650-5.
62. Kaojarern S, Supmonchai K, Phuapradit P, Mokkhavesa C, Krittiyanunt S. Effect of steroids on cerebrospinal fluid penetration of antituberculous drugs in tuberculous meningitis. Clin Pharmacol Ther. 1991;49:6-12.
63. Romero JA, Kuczeler FJ. Isoniazid overdose: recognition and management. Am Fam Physician 1998;57:749-52.
64. Topcu I, Yentur EA, Kefi A, Ekici NZ, Sakarya M. Seizures, metabolic acidosis and coma resulting from acute isoniazid intoxication. Anesth Intensive Care 2005;33:518-20.
65. Thwaites GE, Lan NT, Dung NH, Quy HT, Oanh DT, Thoa NT, et al. Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis. The Journal of infectious diseases. 2005;192:79-88.
66. Donald PR, Maher D, Maritz JS, Qazi S. Ethambutol dosage for the treatment of children: literature review and recommendations. Int J Tuberc Lung Dis. 2006;10:1318-30.
67. Mehlhorn AJ, Brown DA. Safety concerns with fluoroquinolones. Ann Pharmacother. 2007;41:1859-66.
68. Thwaites GE, Nguyen DB, Nguyen HD, Hoang TQ, Do TT, Nguyen TC, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. The New England journal of medicine. 2004;351:1741-51.
69. Prasad K, Singh MB. Corticosteroids for managing tuberculous meningitis. Cochrane database of systematic reviews (Online). 2008(1):CD002244.
70. Roberts MT, Mendelson M, Meyer P, Carmichael A, Lever AM. The use of thalidomide in the treatment of intracranial tuberculomas in adults: two case reports. The Journal of infection. 2003;47:251-5.
71. Sharma SK, Singla R, Sarda P, Mohan A, Makharia G, Jayaswal A, Sreenivas V, Singh S. Safety of 3 different reintroduction regimens of antituberculosis drugs after development of antituberculosis treatmentinduced hepatotoxicity. Clin Infect Dis. 2010;50:833-9.
72. Cárdenas G, Soto-Hernández JL, Orozco RV, Silva EG, Revuelta R, Amador JL. Tuberculous brain abscesses in immunocompetent patients: management and outcome. Neurosurgery. 2010;67:1081-7.
73. Rajshekhar V. Management of hydrocephalus in patients with tuberculous meningitis. Neurol India. 2009;57:368-74.
74. Jain AK, Dhammi IK. Tuberculosis of the spine: a review. Clinical orthopaedics and related research. 2007;460:39-49.
75. Holdiness MR. Management of tuberculous meninglitis. Drugs 1990;39:224-33.
76. Wallace RC, Burton EM, Barrett FF, Leggiadro RJ, Gerald BE, Lasater OE. Intracranial tuberculosis in children: CT appearance and clinical outcome. Pediatr Radiol 1991;21:241-6.